NewsVast Therapeutics Expands Leadership Team with Appointment of Dr. Paul Bruinenberg as Chief Medical Officer - March 7, 2024
|
|
TechnologyOur proprietary portfolio of small and large molecule new chemical entities deliver broad-spectrum antimicrobial activity without the risk of developing drug resistance.
|